Skip to main content
. 2024 Jul 8;37:12942. doi: 10.3389/ti.2024.12942

TABLE 4.

Comparison between cases with and without AMR in the whole cohort of patients.

No AMR (n = 185) AMR (n = 28) p-value
Donor age, years 45 (36–55) 42 (30–46) 0.07
Donor gender, n (%) (missing cases = 5) Male 82 (45) 18 (67) 0.04
Female 99 (55) 9 (33)
Donor ethnicity, n (%) (missing cases = 8) White 156 (88) 20 (74) 0.07
Ethnic minorities 22 (12) 7 (26)
Recipient age, years 45 (35–55) 43 (31–48) 0.18
Recipient gender, n (%) Male 97 (52) 9 (32) 0.06
Female 88 (48) 19 (68)
Recipient ethnicity, n (%) White 160 (87) 20 (71) 0.05
Ethnic minorities 25 (13) 8 (29)
Recipient dialysis status, n (%) Pre-emptive 51 (28) 2 (7) 0.03
HD or PD 134 (72) 26 (93)
Duration on dialysis, months 17 (0–47) 44 (12–104) 0.002
Peak cRF 97 (81–99) 98 (95–100) 0.15
Total DSA MFI, baseline 9,125 (5,355–15530) 18,700 (7,017–40007) 0.005
Number of previous transplants, n (%) First transplant 123 (66) 18 (64) 0.83
Second or more 62 (34) 10 (36)
High risk relation between recipient and donor, n (%) No 147 (80) 17 (61) 0.03
Yes 38 (20) 11 (39)
HLA mismatch level, n (%) Level 0, 1 and 2 37 (20) 7 (25) 0.61
Level 3 and 4 148 (80) 21 (75)
DSA to repeat mismatch, n (%) (missing cases = 6) No 145 (80) 10 (38) <0.001
Yes 36 (20) 16 (62)

Values expressed as Median (IQR), unless otherwise stated. Abbreviations: HD, hemodialysis; PD, peritoneal dialysis; cRF, calculated reaction frequency; HLA, human leukocyte antigen; DSA MFI, Donor specific antibody-mean fluorescence index. *DSA MFI, and cRF, values are presented only for HLAi, and high-risk transplant.